Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 4

1.

Follow-up of phase I trial of adalimumab and rosiglitazone in FSGS: III. Report of the FONT study group.

Peyser A, Machardy N, Tarapore F, Machardy J, Powell L, Gipson DS, Savin V, Pan C, Kump T, Vento S, Trachtman H.

BMC Nephrol. 2010 Jan 29;11:2. doi: 10.1186/1471-2369-11-2.

PMID:
20113498
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Diagnostic yield of renal biopsies: a retrospective single center review.

Scheckner B, Peyser A, Rube J, Tarapore F, Frank R, Vento S, Hoffman C, Valderrama E, Charney D, Goilav B, Trachtman H.

BMC Nephrol. 2009 May 21;10:11. doi: 10.1186/1471-2369-10-11.

PMID:
19460162
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

IgA nephropathy: a twenty year retrospective single center experience.

Rube J, Peyser A, Tarapore F, Scheckner B, Frank R, Vento S, Hoffman C, Charney D, Valderamma E, Goilav B, Trachtman H.

Clin Med Pediatr. 2009 Feb 18;3:19-22. Print 2009.

PMID:
23818791
[PubMed]
Free PMC Article
4.

Pilot study of mycophenolate mofetil for treatment of kidney disease due to congenital urinary tract disorders in children.

Trachtman H, Christen E, Frank R, Rini J, Palestro C, Perelstein E, Weiss L, Tarapore F, Fortune S, Horowitz J.

Am J Kidney Dis. 2008 Oct;52(4):706-15. doi: 10.1053/j.ajkd.2008.03.035. Epub 2008 Jun 13.

PMID:
18554762
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk